While private citizens not associated with the family brand, the Boehringer and Von Baumbach families control the German pharmaceutical company Boehringer Ingelheim. For over 100 years, they have led the biotech industry, designing everything from HIV drugs to cancer therapeutics. The Boehringer and Von Baumbach families are worth over $50 billion.

This site offers information designed for educational purposes only. The information on this Website is not intended to be comprehensive, nor does it constitute advice or our recommendation in any way. We attempt to ensure that the content is current and accurate but we do not guarantee its currency and accuracy. You should carry out your own research and/or seek your own advice before acting or relying on any of the information on this Website.